vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与Forian Inc.（FORA）财务数据对比。点击上方公司名可切换其他公司
CAPRICOR THERAPEUTICS, INC.的季度营收约是Forian Inc.的1.4倍（$11.1M vs $8.0M），Forian Inc.净利率更高（-22.9% vs -63.9%，领先41.1%），Forian Inc.同比增速更快（37.0% vs -7.9%），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs 27.8%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商，提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务，客户覆盖生物制药企业、医疗机构及生命科学领域相关机构，助力提升诊疗效率、推动医学研究进展。
CAPR vs FORA — 直观对比
营收规模更大
CAPR
是对方的1.4倍
$8.0M
营收增速更快
FORA
高出44.9%
-7.9%
净利率更高
FORA
高出41.1%
-63.9%
两年增速更快
CAPR
近两年复合增速
27.8%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $8.0M |
| 净利润 | $-7.1M | $-1.8M |
| 毛利率 | — | 49.2% |
| 营业利润率 | -69.1% | -24.4% |
| 净利率 | -63.9% | -22.9% |
| 营收同比 | -7.9% | 37.0% |
| 净利润同比 | -833.8% | -1012.2% |
| 每股收益（稀释后） | $-0.11 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRFORA
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $7.1M | ||
| Q4 24 | $11.1M | $5.8M | ||
| Q3 24 | $2.3M | $4.7M | ||
| Q2 24 | $4.0M | $4.8M | ||
| Q1 24 | $4.9M | $4.9M |
净利润CAPRFORA
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-151.2K | ||
| Q2 25 | — | $224.8K | ||
| Q1 25 | — | $-1.1M | ||
| Q4 24 | $-7.1M | $199.7K | ||
| Q3 24 | $-12.6M | $-204.9K | ||
| Q2 24 | $-11.0M | $-2.6M | ||
| Q1 24 | $-9.8M | $-1.2M |
毛利率CAPRFORA
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 51.6% | ||
| Q2 25 | — | 56.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 58.3% | ||
| Q3 24 | — | 70.1% | ||
| Q2 24 | — | 62.2% | ||
| Q1 24 | — | 65.1% |
营业利润率CAPRFORA
| Q4 25 | — | -24.4% | ||
| Q3 25 | — | -6.1% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | -69.1% | -24.9% | ||
| Q3 24 | -575.2% | -17.0% | ||
| Q2 24 | -291.9% | -62.2% | ||
| Q1 24 | -209.2% | -36.3% |
净利率CAPRFORA
| Q4 25 | — | -22.9% | ||
| Q3 25 | — | -1.9% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | -63.9% | 3.4% | ||
| Q3 24 | -555.2% | -4.4% | ||
| Q2 24 | -277.0% | -53.4% | ||
| Q1 24 | -199.6% | -24.9% |
每股收益（稀释后）CAPRFORA
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | $-0.11 | $0.01 | ||
| Q3 24 | $-0.38 | $-0.01 | ||
| Q2 24 | $-0.35 | $-0.08 | ||
| Q1 24 | $-0.31 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $31.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $29.8M |
| 总资产 | $170.5M | $44.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAPRFORA
| Q4 25 | — | $31.6M | ||
| Q3 25 | — | $28.2M | ||
| Q2 25 | — | $35.6M | ||
| Q1 25 | — | $35.7M | ||
| Q4 24 | $151.5M | $35.1M | ||
| Q3 24 | $85.0M | $49.4M | ||
| Q2 24 | $29.5M | $48.0M | ||
| Q1 24 | $39.9M | $47.4M |
股东权益CAPRFORA
| Q4 25 | — | $29.8M | ||
| Q3 25 | — | $31.1M | ||
| Q2 25 | — | $30.9M | ||
| Q1 25 | — | $30.0M | ||
| Q4 24 | $145.5M | $30.1M | ||
| Q3 24 | $68.3M | $28.4M | ||
| Q2 24 | $11.5M | $27.2M | ||
| Q1 24 | $18.4M | $28.1M |
总资产CAPRFORA
| Q4 25 | — | $44.1M | ||
| Q3 25 | — | $41.3M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | — | $48.6M | ||
| Q4 24 | $170.5M | $47.2M | ||
| Q3 24 | $93.0M | $57.5M | ||
| Q2 24 | $38.3M | $58.4M | ||
| Q1 24 | $49.4M | $57.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | — |
| 自由现金流率自由现金流/营收 | -137.3% | — |
| 资本支出强度资本支出/营收 | 4.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.2M | — |
8季度趋势，按日历期对齐
经营现金流CAPRFORA
| Q4 25 | — | $3.2M | ||
| Q3 25 | — | $-439.7K | ||
| Q2 25 | — | $-344.5K | ||
| Q1 25 | — | $448.2K | ||
| Q4 24 | $-14.8M | $1.7M | ||
| Q3 24 | $-11.6M | $764.1K | ||
| Q2 24 | $-12.3M | $-23.1K | ||
| Q1 24 | $-1.3M | $-2.2M |
自由现金流CAPRFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-15.3M | — | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-12.3M | — | ||
| Q1 24 | $-1.9M | — |
自由现金流率CAPRFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -137.3% | — | ||
| Q3 24 | -515.2% | — | ||
| Q2 24 | -310.9% | — | ||
| Q1 24 | -38.3% | — |
资本支出强度CAPRFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.4% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 12.4% | 0.0% |
现金转化率CAPRFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPR
暂无分部数据
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
